[Megestrol acetate versus medroxyprogesterone acetate in the treatment of metastasizing breast cancers. Intermediate report of a multicenter phase III study]

Onkologie. 1987 Apr;10(2):104-6. doi: 10.1159/000216383.
[Article in German]
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Female
  • Humans
  • Male
  • Medroxyprogesterone / analogs & derivatives*
  • Medroxyprogesterone / therapeutic use
  • Medroxyprogesterone Acetate
  • Megestrol / analogs & derivatives*
  • Megestrol / therapeutic use
  • Megestrol Acetate
  • Middle Aged
  • Neoplasm Metastasis
  • Random Allocation

Substances

  • Antineoplastic Agents
  • Medroxyprogesterone Acetate
  • Megestrol
  • Medroxyprogesterone
  • Megestrol Acetate